CHD2 mutations in Lennox-Gastaut syndrome

Epilepsy and Behavior

Volumn 33, Issue , 2014, Pages 18-21

  Lund, Caroline ^a   Brodtkorb, Eylert ^b,c   Øye, Ane Marte ^a   Røsby, Oddveig ^a   Selmer, Kaja Kristine ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

CHD2; Epileptic encephalopathy; Lennox Gastaut syndrome; Sanger sequencing

Indexed keywords

CHD2 PROTEIN; DNA BINDING PROTEIN; PETROLEUM; UNCLASSIFIED DRUG; CHD2 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; FRAMESHIFT MUTATION; GENE DUPLICATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; LENNOX GASTAUT SYNDROME; MYOCLONUS SEIZURE; PHENOTYPE; PHOTOSENSITIVITY; POINT MUTATION; RISK FACTOR; SANGER SEQUENCING; SEQUENCE ANALYSIS; STOP CODON; YOUNG ADULT; BRAIN; ELECTROENCEPHALOGRAPHY; GENETICS; MALE; MUTATION; PATHOPHYSIOLOGY;

ADULT; BRAIN; DNA-BINDING PROTEINS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; LENNOX GASTAUT SYNDROME; MALE; MUTATION;

EID: 84895735355     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.02.005     Document Type: Article

References (12)

1. Arzimanoglou A., French J., Blume W.T., Cross J.H., Ernst J.P., Feucht M., et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009, 8(1):82-93.
2. Genton P., Dravet C. Lennox-Gastaut syndrome. Epilepsy: a comprehensive textbook 2008, 2417-2453. Lippincott Williams & Wilkins, Philadelphia. J. Engel, T.A. Pedley (Eds.).
3. Carvill G.L., Heavin S.B., Yendle S.C., McMahon J.M., O'Roak B.J., Cook J., et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013, 45(7):825-830.
4. Allen A.S., Berkovic S.F., Cossette P., Delanty N., Dlugos D., Eichler E.E., et al. De novo mutations in epileptic encephalopathies. Nature 2013, 501(7466):217-221.
5. Suls A., Jaehn J.A., Kecskes A., Weber Y., Weckhuysen S., Craiu D.C., et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet 2013, 93(5):967-975.
6. Capelli L.P., Krepischi A.C., Gurgel-Giannetti J., Mendes M.F., Rodrigues T., Varela M.C., et al. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency. Eur J Med Genet 2012, 55(2):132-134.
7. Rauch A., Wieczorek D., Graf E., Wieland T., Endele S., Schwarzmayr T., et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012, 380(9854):1674-1682.
8. Dhamija R., Breningstall G., Wong-Kisiel L., Dolan M., Hirsch B., Wirrell E. Microdeletion of chromosome 15q26.1 in a child with intractable generalized epilepsy. Pediatr Neurol 2011, 45(1):60-62.
9. Veredice C., Bianco F., Contaldo I., Orteschi D., Stefanini M.C., Battaglia D., et al. Early onset myoclonic epilepsy and 15q26 microdeletion: observation of the first case. Epilepsia 2009, 50(7):1810-1815.
10. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485(7397):242-245.
11. Lund C., Brodtkorb E., Rosby O., Rodningen O.K., Selmer K.K. Copy number variants in adult patients with Lennox-Gastaut syndrome features. Epilepsy Res 2013, 105(1-2):110-117.
12. Selmer K.K., Lund C., Brandal K., Undlien D.E., Brodtkorb E. SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features. Epilepsy Behav 2009, 16(3):555-557.